Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization.

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• Memantine and ketamine are NMDA receptor (NMDAR) channel blockers with similar potency but different clinical outcomes.
• This discrepancy is hypothesized to stem from differential inhibition of NMDAR subpopulations.
• The mechanisms underlying this location-dependent inhibition remain unclear.

Purpose of the Study:

• To investigate the mechanisms by which channel blockers distinguish NMDAR subpopulations based on subcellular location.
• To explore how memantine and ketamine differentially affect NMDAR desensitization.
• To identify potential strategies for developing NMDAR-selective drugs with improved clinical profiles.

Main Methods:

• Recordings from heterologously expressed single NMDAR subtypes.
• Kinetic modeling of NMDAR function.
• Recordings of synaptically evoked NMDAR responses in acute brain slices.

Main Results:

• Memantine and ketamine differentially alter NMDAR desensitization.
• Memantine stabilizes a Ca2+-dependent desensitized state, particularly for GluN1/2A and native synaptic NMDARs.
• This effect is enhanced under conditions of increased intracellular Ca2+ accumulation.

Conclusions:

• Differential inhibition of NMDAR subpopulations by memantine and ketamine is likely due to location-dependent NMDAR activation intensity and duration.
• Modulation of Ca2+-dependent NMDAR desensitization is a novel mechanism for achieving NMDAR selectivity.
• Targeting specific receptor states, rather than types, presents a viable strategy for future drug development in neuroprotection.